8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2005 / Systematic review of human intervention trials
A systematic review screened 415 publications and included 23 human intervention trials investigating the independent effects of nuts on blood lipids. Due to large differences in study designs, no formal statistical analysis was performed. Results from 3 almond (50-100 g/d), 2 peanut (35-68 g/d), 1 pecan (72 g/d), and 4 walnut (40-84 g/d) studies showed decreases in total cholesterol between 2% and 16% and LDL cholesterol between 2% and 19% compared with control diets, while macadamia nuts (50-100 g/d) yielded less convincing results. The authors conclude that consuming approximately 50-100 g of nuts at least 5 times per week in a heart-healthy diet may significantly decrease total and LDL cholesterol.
Mukuddem-Petersen J, Oosthuizen W, Jerling JC J Nutr, 2005. PMID 16140880
2005 / Narrative review
This review examines the regulatory framework of the Dietary Supplement Health and Education Act of 1994 (DSHEA) and the history of ephedra, a supplement used for weight loss. Due to sympathomimetic activity, ephedra caused stroke, cardiac arrhythmia, and death, prompting an FDA ban on its sale effective April 12, 2004. An evaluation of other dietary supplements attempting to fill the void demonstrates a general lack of safety and efficacy data. Ten years after DSHEA, the industry remains controversial and a concern for consumer safety.
Seamon MJ, Clauson KA J Herb Pharmacother, 2005. PMID 16520299
2004 / Narrative review
This review notes that normal low-density lipoprotein (LDL) cholesterol is 50 to 70 mg/dl for native hunter-gatherers, healthy human neonates, free-living primates, and other wild mammals, none of whom develop atherosclerosis. Randomized trial data suggest atherosclerosis progression and coronary heart disease events are minimized when LDL is lowered to <70 mg/dl. No major safety concerns have surfaced in studies lowering LDL to 50 to 70 mg/dl, while guidelines targeting 100 to 115 mg/dl may lead to substantial undertreatment in high-risk individuals.
O'Keefe JH, Cordain L, Harris WH, et al. J Am Coll Cardiol, 2004. PMID 15172426
2004 / Narrative review
This review evaluates available evidence regarding sorghum phytochemicals, including tannins, phenolic acids, anthocyanins, phytosterols, and policosanols. Sorghum fractions demonstrate high antioxidant activity in vitro compared to other cereals or fruits. Available epidemiological evidence suggests sorghum consumption reduces the risk of certain cancers in humans relative to other cereals. Additionally, animal studies report that tannin-containing sorghums reduce weight gain and promote cardiovascular health, though human cardiovascular properties remain unconfirmed and require investigation.
Shows an association, not proof of cause and effect.
Awika JM, Rooney LW Phytochemistry, 2004. PMID 15184005
2004 / Narrative review
This review examines the nutritional composition of edible wild plants and the physiological roles of omega-3 and omega-6 fatty acids. Edible wild plants supply alpha-linolenic acid (ALA) and higher levels of vitamins E and C, phenols, and other antioxidant compounds than cultivated plants. In reviewed clinical research, ALA intake contributed to reduced blood pressure and showed inhibitory effects on platelet clotting, while an epidemiological study linked ALA inversely to coronary heart disease risk in men. The review notes that high dietary linoleic acid and body fat reserves of linoleic acid can slow the conversion of ALA to longer-chain omega-3 fatty acids.
Simopoulos AP Biol Res, 2004. PMID 15455656
2004 / Narrative review of metabolically controlled studies
The authors reviewed a series of metabolically controlled studies combining four cholesterol-lowering dietary components—viscous fibers, plant sterols, soy protein, and nuts—into a single 'dietary portfolio'. This portfolio diet reduced low-density lipoprotein cholesterol by approximately 30% and produced clinically significant reductions in coronary heart disease risk. These reductions were reported to match those achieved with a starting dose of a first-generation statin drug.
Kendall CW, Jenkins DJ Curr Atheroscler Rep, 2004. PMID 15485596
2004 / Narrative review
This review evaluated potential adverse effects of oral creatine supplementation on gastrointestinal, cardiovascular, musculoskeletal, renal, and liver functions. No strong evidence linked creatine use to the deterioration of these functions, and reports of muscle cramps or altered laboratory values largely remain anecdotal. The only documented side effect reported was an increase in body mass. In healthy subjects, oral creatine supplementation, even at long-term dosages, is considered an effective and safe ergogenic aid, though contaminants from industrial production are a potential concern.
Bizzarini E, De Angelis L J Sports Med Phys Fitness, 2004. PMID 15758854
2004 / Narrative review
This review summarizes evidence on whole grains and human health. Epidemiological studies find whole-grain intake is protective against cancer, CVD, diabetes, and obesity, whereas typical intake in Western countries is about one serving per day despite recommendations for three servings daily. Published feeding studies report biomarker improvements, including weight loss, improved blood lipids, and antioxidant protection. The authors note that disease protection observed in prospective studies exceeds that seen from isolated nutrients, though separating protective properties of whole grains from fiber and other components remains challenging.
Shows an association, not proof of cause and effect.
Slavin J Nutr Res Rev, 2004. PMID 19079919
2003 / Narrative review
This review examines the role of tomatoes and their constituents in cardiovascular health. Tomatoes provide lycopene, beta-carotene, folate, potassium, vitamin C, flavonoids, and vitamin E, with processing affecting their bioavailability. Nutrients in tomatoes are hypothesized to protect lipoproteins and vascular cells from oxidation, an effect supported by in vitro, limited in vivo, and epidemiological evidence. Other potential cardioprotective mechanisms associated with tomato nutrients include reductions in LDL cholesterol, homocysteine, platelet aggregation, and blood pressure.
Willcox JK, Catignani GL, Lazarus S Crit Rev Food Sci Nutr, 2003. PMID 12587984
2003 / Hypothesis / narrative review
This article discusses the concept that a salted, rich diet initiates metabolic cycles sustaining hypertension even after salt reduction. It highlights prior findings showing that a water-only fast followed by a low-fat, low-salt whole-food vegan diet restored normotension in the majority of hypertensive patients without medication. Available follow-up data suggest blood pressure reductions can be maintained with continued dietary compliance, though long-term follow-up remains sporadic.
McCarty MF Med Hypotheses, 2003. PMID 12710893
2003 / Narrative review
This review examines the health effects of rye, plant lignans, and the dietary fibre complex. Human evidence does not currently warrant the conclusion that rye, whole grains, or phyto-oestrogens protect against cancer, though some studies suggest benefits for upper digestive tract cancers. Conversely, prospective epidemiological studies demonstrate protective effects of wholegrain cereals against myocardial infarction, diabetes, and ischaemic stroke, likely tied to factors within the dietary fibre complex.
Shows an association, not proof of cause and effect.
Hallmans G, Zhang JX, Lundin E, et al. Proc Nutr Soc, 2003. PMID 12749346
2003 / Editorial
This editorial discusses dietary phosphorus as a determinant of serum phosphorus, which is linked to increased cardiovascular morbidity and mortality in dialysis patients. Average daily dietary phosphorus intake is about 1550 mg for males and 1000 mg for females, with high-protein foods generally high in phosphorus. Phosphates added to processed foods such as meats, cheeses, dressings, beverages, and bakery items can increase phosphorus intake by as much as 1 g/day. Because nutrient composition tables usually omit phosphorus from these additives, dietary phosphorus intake may be underestimated.
Uribarri J, Calvo MS Semin Dial, 2003. PMID 12753675
2003 / Narrative review
This review argues that lipid management should shift focus from fasting levels to postprandial states and clinical outcomes. Meals high in animal fat impair endothelial function for 4 hours, an effect minimized by antioxidant vitamins, and one egg yolk increases oxidized LDL by 34% while raising fasting LDL by approximately 10%. In coronary patients, the Lyon Diet Heart Study and the IndoMediterranean Diet study showed that a Mediterranean diet reduced myocardial infarction and death by 60% over 4 years and 50% over 2 years, respectively, compared to standard diets despite no differences in fasting lipids.
NANO counterpoint →
Spence JD Can J Cardiol, 2003. PMID 12876608
2003 / Narrative review
This review discusses the evolutionary context of plant-based diets and cholesterol regulation. In experimental work cited, introducing high intakes of viscous fibers, vegetable proteins, and plant sterols via a possible Miocene diet of leafy vegetables, fruit, and nuts lowered serum LDL-cholesterol in healthy volunteers by over 30%. In hyperlipidemic subjects, supplementing a therapeutic diet with these components (from oat, barley, psyllium, soy, almonds, and plant sterol-enriched margarine) yielded similar LDL-cholesterol reductions and normalized blood lipid concentrations in most participants.
Jenkins DJ, Kendall CW, Marchie A, et al. Comp Biochem Physiol A Mol Integr Physiol, 2003. PMID 14527636
2003 / Narrative review
This review examines the relationship between stress-induced hypothalamic-pituitary-adrenal (HPA) axis activation and visceral obesity. Activation of the HPA axis elevates cortisol production, which promotes hyperphagic and antithermogenic effects and preferentially affects abdominal adipose tissue due to higher glucocorticoid receptor density, blood flow, and cellularity. While the literature cannot clearly determine causality, it suggests visceral obesity may be a non-optimal physiological adaptation to stress, where stress management and weight loss strategies could help disrupt the cycle.
Shows an association, not proof of cause and effect.
Drapeau V, Therrien F, Richard D, et al. Panminerva Med, 2003. PMID 14618117
2003 / Narrative review with longitudinal case-study analysis
This article examines the nutrition transition across the developing world, highlighting shifts toward higher energy density, high-fat diets, and increased animal source foods (ASF). Using China as a case study, descriptive and longitudinal analyses show that these dietary transitions and obesity patterns are accelerating. The author notes that developing countries face obesity rates surpassing undernutrition, raising concerns for cardiovascular disease, saturated fat intake, and energy imbalance related to livestock promotion policies.
Shows an association, not proof of cause and effect.
Popkin BM, Du S J Nutr, 2003. PMID 14672288
2002 / Review
Platelet hyperactivity is a significant factor in the incidence of cardiovascular disease. Various nutritive and non-nutritive compounds present in the diet may influence platelet function. This review summarizes the in vitro and in vivo effects of anti-platelet factors derived from plants, vegetables, and fruits on human platelet activity.
Dutta-Roy AK Platelets, 2002. PMID 11897042
2002 / Narrative review
This review summarizes harmful effects of dietary salt beyond raising blood pressure. High salt intake increases left ventricular mass, thickens and stiffens conduit arteries, thickens and narrows resistance arteries, increases stroke incidence, worsens cardiac failure, and enhances platelet aggregation. It also accelerates renal functional decline in renal disease, affects calcium and bone metabolism linked to bone density in post-menopausal women, influences gastric carcinoma incidence, and may relate to asthma severity in males.
de Wardener HE, MacGregor GA J Hum Hypertens, 2002. PMID 11967714
2002 / Narrative commentary / perspective
This commentary discusses the roles of genetic and environmental influences, including diet and life-style, on cardiovascular disease, cancers, and major causes of mortality. The author argues that environmental factors are most important and warns that overly enthusiastic expectations for genetic research could distort health spending priorities. Integrating genetic information into epidemiologic studies is highlighted as a balanced approach to clarify causal links and inform disease prevention strategies.
Willett WC Science, 2002. PMID 11976443
2002 / Narrative review
The glycemic index was proposed in 1981 to classify carbohydrate-containing foods. Despite numerous scientific and popular publications, its clinical significance remains debated. This review examines the physiological effects of the glycemic index and their relevance in preventing and treating obesity, diabetes, and cardiovascular disease.
Ludwig DS JAMA, 2002. PMID 11988062
2002 / Narrative review of community intervention and national programme
This paper discusses experiences from the North Karelia Project launched in 1972 and subsequent national programs in Finland aimed at modifying diet and lifestyles to prevent cardiovascular disease. Evaluations indicated that dietary changes, particularly in fat consumption, led to major reductions in population serum cholesterol and blood pressure levels. Between 1971 and 1995, ischaemic heart disease mortality in the working-age population declined by 73% in North Karelia and by 65% in the whole country.
Pekka P, Pirjo P, Ulla U Public Health Nutr, 2002. PMID 12027291
2002 / Narrative review
This review examines the roles of creatine and creatine kinase in health and disease. Oral creatine supplementation improved clinical symptoms in patients with AGAT and GAMT deficiencies, though not in creatine transporter deficiency. Additionally, it showed neuroprotective effects in animal models of Huntington's disease, Parkinson's disease, and amyotrophic lateral sclerosis. The authors note creatine may also reduce plasma homocysteine production to potentially lower atherosclerotic risk, but these findings require confirmation and safety evaluations in human clinical studies.
Wyss M, Schulze A Neuroscience, 2002. PMID 12044443
2002 / Narrative review
This article reviews evidence on dietary cholesterol and atherosclerosis from animal experiments, plaque chemistry, epidemiology, and human feeding studies. It reports that dietary cholesterol is a major factor promoting atherosclerotic plaque growth by increasing its cholesterol content. The author notes that confusion has occurred because intakes above a ceiling quantity do not further increase plasma and LDL cholesterol, and states the therapeutic threshold is below 100 mg/d.
Connor WE, Connor SL Curr Atheroscler Rep, 2002. PMID 12361489
2002 / Narrative review
This review examines the biology, formation, and clinical data regarding equol, a nonsteroidal estrogen produced exclusively by intestinal bacteria from the soy isoflavone daidzein. Equol possesses affinity for estrogen receptors ERalpha and ERbeta and exhibits superior antioxidant activity compared to other isoflavones. Because equol is not produced in all adults, maximal clinical responses to soy diets in cardiovascular, bone, and menopausal health are seen in 'equol-producers.' The authors propose that classifying individuals by their equol-producing status could explain historical variance in soy intervention outcomes.
Setchell KD, Brown NM, Lydeking-Olsen E J Nutr, 2002. PMID 12468591